(E)-4-Hydroxytamoxifen

CAS No. 174592-47-3

(E)-4-Hydroxytamoxifen( —— )

Catalog No. M37969 CAS No. 174592-47-3

(E)-4-Hydroxytamoxifen ((E)-Afimoxifene), the less active isomer of (Z)-4-hydroxytamoxifen, is an estrogen receptor modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 92 In Stock
10MG 118 In Stock
25MG 254 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (E)-4-Hydroxytamoxifen
  • Note
    Research use only, not for human use.
  • Brief Description
    (E)-4-Hydroxytamoxifen ((E)-Afimoxifene), the less active isomer of (Z)-4-hydroxytamoxifen, is an estrogen receptor modulator.
  • Description
    (E)-4-Hydroxytamoxifen ((E)-Afimoxifene), the less active isomer of (Z)-4-hydroxytamoxifen, is an estrogen receptor modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    174592-47-3
  • Formula Weight
    387.51
  • Molecular Formula
    C26H29NO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 12.5 mg/mL (32.26 mM)
  • SMILES
    OC1=CC=C(C=C1)/C(C2=CC=C(C=C2)OCCN(C)C)=C(CC)\C3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 6-O-Acetylastragalin

    Kaempferol 7-O-beta-d-glucopyranoside (6''-O-Acetylastragalin) is a novel supercoolant, to sub-zero non-freezing rat heart preservation.

  • (Rac)-IBT6A

    (Rac)-IBT6A is a racemate of IBT6A. IBT6A is an impurity of Ibrutinib and can be used in the synthesis of IBT6A Ibrutinib dimer and IBT6A adduct.

  • Tegadifur

    Tegadifur (40497S) is an orally available antitumor compound with antimetabolic effects, often used with uracil and in the treatment of rectal adenocarcinoma.